Centessa Pharmaceuticals Statistics Share Statistics Centessa Pharmaceuticals has 133.91M
shares outstanding. The number of shares has increased by 18%
in one year.
Shares Outstanding 133.91M Shares Change (YoY) 18% Shares Change (QoQ) 0.7% Owned by Institutions (%) 92.87% Shares Floating 85.14M Failed to Deliver (FTD) Shares 6,180 FTD / Avg. Volume 0.55%
Short Selling Information The latest short interest is 4.65M, so 3.46% of the outstanding
shares have been sold short.
Short Interest 4.65M Short % of Shares Out 3.46% Short % of Float 4.08% Short Ratio (days to cover) 4.19
Valuation Ratios The PE ratio is -8.13 and the forward
PE ratio is -9.89.
Centessa Pharmaceuticals's PEG ratio is
-0.26.
PE Ratio -8.13 Forward PE -9.89 PS Ratio 0 Forward PS 638.7 PB Ratio 4.78 P/FCF Ratio -13.49 PEG Ratio -0.26
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Centessa Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 9.25,
with a Debt / Equity ratio of 0.29.
Current Ratio 9.25 Quick Ratio 9.25 Debt / Equity 0.29 Debt / EBITDA -0.53 Debt / FCF -0.83 Interest Coverage -19.92
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-3.06M Employee Count 77 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 2.84M Effective Tax Rate -1.22%
Stock Price Statistics The stock price has increased by 20.76% in the
last 52 weeks. The beta is 1.48, so Centessa Pharmaceuticals's
price volatility has been higher than the market average.
Beta 1.48 52-Week Price Change 20.76% 50-Day Moving Average 15.98 200-Day Moving Average 15.28 Relative Strength Index (RSI) 61.42 Average Volume (20 Days) 1,119,447
Income Statement
Revenue n/a Gross Profit -942.4K Operating Income -201.06M Net Income -235.76M EBITDA -221.97M EBIT -222.92M Earnings Per Share (EPS) -2.06
Full Income Statement Balance Sheet The company has 383.22M in cash and 117.23M in
debt, giving a net cash position of 266M.
Cash & Cash Equivalents 383.22M Total Debt 117.23M Net Cash 266M Retained Earnings -988.7M Total Assets 492.13M Working Capital 270.67M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -142.06M
and capital expenditures -34K, giving a free cash flow of -142.09M.
Operating Cash Flow -142.06M Capital Expenditures -34K Free Cash Flow -142.09M FCF Per Share -1.24
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
